See also this year's filing and all EDGAR filings for this company.
PDF Report 0001433714_2016_Castlight_Health_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | No stock price available | subcommand.plot | {} |
| warning | No LiabilitiesAndStockholdersEquity node found | input.sec.calculation_linkbase.edgar_model_mapping | {'lase_node': None, 'equity_node': None, 'partners_cap_node': None, 'nodes': "NodeView(('AssetsCurrent', 'Assets', 'PropertyPlantAndEquipmentNet', 'AvailableForSaleSecuritiesNoncurrent', 'RestrictedCashAndCashEquivalentsNoncurrent', 'DeferredSalesCommissionsNoncurrent', 'OtherAssetsNoncurrent', 'CashAndCashEquivalentsAtCarryingValue', 'AvailableForSaleSecuritiesCurrent', 'AccountsReceivableNetCurrent', 'DeferredSalesCommissionsCurrent', 'PrepaidExpenseAndOtherAssetsCurrent', 'LiabilitiesCurrent', 'Liabilities', 'DeferredRevenueNoncurrent', 'OtherLiabilitiesNoncurrent', 'AccountsPayableCurrent', 'AccruedLiabilitiesandOtherAccruedLiabilitiesCurrent', 'EmployeeRelatedLiabilitiesCurrent', 'DeferredRevenueCurrent'))"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001433714')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001433714, Castlight Health INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 142,385,000 |
| 1 | AssetsNonCurrent | 11,631,000 |
| 2 | IntangibleAssets | 0 |
| 3 | remainder_Assets | 19,258,000 |
| 4 | LiabilitiesCurrent | 53,523,000 |
| 5 | LiabilitiesNonCurrent | 1,397,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingExpense | 67,414,000 |
| 9 | GeneralAndAdministrativeExpense | 24,274,000 |
| 10 | ResearchAndDevelopment | 30,077,000 |
| 11 | DepreciationDepletionAndAmortization | 0 |
| 12 | remainder_Expenses | 0 |
| 13 | remainder_Revenues | 0 |
| 14 | remainder_NetIncome | 41,845,000 |
| 15 | remainder_ComprehensiveNetIncome | -39,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 173,274,000 |
| 1 | Liabilities | 54,920,000 |
| 2 | Expenses | 121,765,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 118,354,000 |
| 5 | NetIncome | -79,920,000 |
| 6 | ComprehensiveNetIncome | -79,959,000 |
| 7 | BaseVar | 195,921,500 |
| 8 | EconomicCapitalRatio | 0.534 |